Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6955007rdf:typepubmed:Citationlld:pubmed
pubmed-article:6955007lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C0870134lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C0005953lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C0010711lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:6955007lifeskim:mentionsumls-concept:C0135096lld:lifeskim
pubmed-article:6955007pubmed:issue10lld:pubmed
pubmed-article:6955007pubmed:dateCreated1982-10-29lld:pubmed
pubmed-article:6955007pubmed:abstractTextThe effect of N-[phosphonacetyl]-L-aspartate (PALA) on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine (ara-C) was studied in the human promyelocytic leukemic cell line, HL-60, and in normal human bone marrow. HL-60 cells exposed to 0.1 mM PALA for 12 hr accumulated 58.7 pmol ara-C per 10(6) cells after a 45-min exposure to 1 microM ara-C, compared to 27.8 pmol ara-C per 10(6) cells in untreated control cells. This PALA concentration and exposure interval was associated with a greater than 2-fold increase in both the 45-min generation and 4-hr retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate compared to untreated control HL-60 cells. Exposure of HL-60 cells to PALA followed by ara-C produced greater than additive effects on the inhibition of DNA synthesis, the inhibition of cell growth, and clonogenicity. In contrast, exposure of normal human bone marrow to the same PALA-ara-C schedule was not associated with a synergistic inhibition of colony-forming units in soft agar. If these perturbations also occur in vivo, an improvement in the therapeutic index of ara-C in patients with acute leukemia might result.lld:pubmed
pubmed-article:6955007pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:languageenglld:pubmed
pubmed-article:6955007pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:citationSubsetIMlld:pubmed
pubmed-article:6955007pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6955007pubmed:statusMEDLINElld:pubmed
pubmed-article:6955007pubmed:monthOctlld:pubmed
pubmed-article:6955007pubmed:issn0008-5472lld:pubmed
pubmed-article:6955007pubmed:authorpubmed-author:CadmanEElld:pubmed
pubmed-article:6955007pubmed:authorpubmed-author:GrantSSlld:pubmed
pubmed-article:6955007pubmed:authorpubmed-author:RauscherFF3rdlld:pubmed
pubmed-article:6955007pubmed:issnTypePrintlld:pubmed
pubmed-article:6955007pubmed:volume42lld:pubmed
pubmed-article:6955007pubmed:ownerNLMlld:pubmed
pubmed-article:6955007pubmed:authorsCompleteYlld:pubmed
pubmed-article:6955007pubmed:pagination4007-13lld:pubmed
pubmed-article:6955007pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:meshHeadingpubmed-meshheading:6955007-...lld:pubmed
pubmed-article:6955007pubmed:year1982lld:pubmed
pubmed-article:6955007pubmed:articleTitleDifferential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors.lld:pubmed
pubmed-article:6955007pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6955007pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6955007pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6955007pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed